IRIS
Demichelis, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.610
AS - Asia 3.225
EU - Europa 2.981
SA - Sud America 729
AF - Africa 70
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 7
Totale 19.655
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.500
SG - Singapore 1.714
CN - Cina 740
BR - Brasile 619
RU - Federazione Russa 541
IT - Italia 464
DE - Germania 329
FI - Finlandia 307
SE - Svezia 305
GB - Regno Unito 269
UA - Ucraina 269
VN - Vietnam 259
LV - Lettonia 161
HK - Hong Kong 152
CA - Canada 69
ID - Indonesia 63
BG - Bulgaria 58
IN - India 54
AR - Argentina 49
ES - Italia 44
AT - Austria 40
FR - Francia 37
PL - Polonia 37
NL - Olanda 34
JO - Giordania 32
JP - Giappone 32
ZA - Sudafrica 31
TR - Turchia 30
AU - Australia 28
IQ - Iraq 28
MX - Messico 28
BD - Bangladesh 25
LU - Lussemburgo 22
PK - Pakistan 14
CO - Colombia 13
KR - Corea 12
MA - Marocco 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
VE - Venezuela 11
EC - Ecuador 10
BE - Belgio 9
KE - Kenya 9
LT - Lituania 9
UZ - Uzbekistan 9
CL - Cile 8
PY - Paraguay 8
LB - Libano 6
RO - Romania 6
UY - Uruguay 6
AZ - Azerbaigian 5
IE - Irlanda 5
IL - Israele 5
IR - Iran 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
NG - Nigeria 4
NP - Nepal 4
PE - Perù 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
KG - Kirghizistan 3
OM - Oman 3
TN - Tunisia 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
EE - Estonia 2
GA - Gabon 2
JM - Giamaica 2
MY - Malesia 2
RS - Serbia 2
TH - Thailandia 2
TJ - Tagikistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MC - Monaco 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MV - Maldive 1
NA - Namibia 1
Totale 19.645
Salva come PNG Salva come JPEG
Città #
Fairfield 1.720
Ashburn 1.270
Singapore 1.049
Chandler 956
Woodbridge 790
Seattle 704
Houston 633
Jacksonville 610
Cambridge 586
Wilmington 567
Dallas 434
Santa Clara 342
San Mateo 334
Ann Arbor 326
Columbus 312
Moscow 246
Princeton 226
Beijing 184
Los Angeles 182
Riga 161
Munich 159
Helsinki 154
Hong Kong 150
Trento 149
New York 134
San Diego 119
London 89
Boardman 84
The Dalles 84
Dearborn 79
Lawrence 70
Ho Chi Minh City 68
Chicago 65
Buffalo 58
Sofia 58
Jakarta 57
São Paulo 57
Como 56
Dong Ket 50
San Francisco 49
Council Bluffs 44
Nuremberg 41
Falls Church 40
Redondo Beach 40
San Jose 38
Hanoi 36
Hefei 35
Bremen 34
Warsaw 28
Denver 27
Norwalk 27
San Paolo di Civitate 27
Salt Lake City 26
Phoenix 25
Toronto 25
Frankfurt am Main 24
Tokyo 23
Tolentino 23
Turku 23
Brasília 22
Hesperange 22
Johannesburg 22
Altamura 21
Des Moines 21
Montreal 21
Washington 21
Belo Horizonte 20
Bend 20
Elk Grove Village 19
Guangzhou 19
Melbourne 19
Barcelona 16
Brooklyn 16
Curitiba 16
Kilburn 16
Rio de Janeiro 16
Vienna 16
Düsseldorf 15
Izmir 15
Orem 15
Baghdad 14
Rome 14
Andover 13
Chennai 13
Lappeenranta 13
Milan 13
Shanghai 13
Boston 12
Kunming 12
Vancouver 12
Poplar 11
Atlanta 10
Bonndorf 10
Miami 10
Nanjing 10
Zhengzhou 10
Brussels 9
Chiswick 9
Haiphong 9
Nairobi 9
Totale 14.621
Salva come PNG Salva come JPEG
Nome #
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 320
Inherited determinants of early recurrent somatic mutations in prostate cancer 308
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer 270
A highly specific SpCas9 variant is identified by in vivo screening in yeast 261
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation 236
ASEQ: Fast allele-specific studies from next-generation sequencing data 223
Patient derived organoids to model rare prostate cancer phenotypes 211
EthSEQ: ethnicity annotation from whole exome sequencing data 208
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 205
Personalized in vitro and in vivo cancer models to guide precision medicine 203
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth 197
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood 196
Genomic correlates of clinical outcome in advanced prostate cancer 186
An evaluation of the use of and user satisfaction with a teleconsultation system in oncology practice. 185
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 182
Second Generation Imaging of Nuclear/Cytoplasmic HIV-1 Complexes. 181
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer 176
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 176
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer 174
Ancestry-specific predisposing germline variants in cancer 170
An automated procedure to properly handle digital images in large scale tissue microarray experiments. 166
Analysis of user-satisfaction with the use of a teleconsultation system in oncology. 164
TPES: Tumor Purity Estimation from SNVs 162
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer 154
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. 149
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data 149
Defining order and timing of mutations during cancer progression: The TO-DAG probabilistic graphical model 148
In-silico identification and functional validation of allele-dependent AR enhancers 145
The landscape of somatic copy-number alteration across human cancers. 144
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. 144
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients 144
Clonal evolution of chemotherapy-resistant urothelial carcinoma 144
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 144
The Molecular Taxonomy of Primary Prostate Cancer 143
A Comparative Study of ERG Status Assessment on DNA, mRNA, and Protein Levels Using Unique Samples from a Swedish Biopsy Cohort. 141
A computational framework discovers new copy number variants with functional importance. 140
Antibody-based detection of ERG rearrangement-positive prostate cancer. 139
A step toward functionally characterized prostate cancer molecular subtypes. 138
EML4-ALK fusion lung cancer: a rare acquired event. 138
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA 138
Genomic correlates to the newly proposed grading prognostic groups for prostate cancer 137
A hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarrays. 136
Testing mutual exclusivity of ETS rearranged prostate cancer. 136
Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer 136
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. 135
Role of non-coding sequence variants in cancer 134
Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. 133
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. 132
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 132
Digital Pathology: Science Fiction? 131
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer. 130
Oncogene-mediated alterations in chromatin conformation 130
Plasma AR and abiraterone-resistant prostate cancer 129
Analytical protocol to identify local ancestry-associated molecular features in cancer 129
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment 128
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. 125
Variants at IRX4 as prostate cancer expression quantitative trait loci. 124
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. 124
Large Oncosomes in Human Prostate Cancer Tissues and in the Circulation of Mice with Metastatic Disease 124
Punctuated evolution of prostate cancer genomes. 123
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets 123
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. 123
JAGGED1 expression is associated with prostate cancer metastasis and recurrence. 123
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. 123
The virtual case: a new method to completely digitize cytological and histological slides. 123
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 122
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. 122
User attitudes in analyzing digital slides in a quality control test bed: a preliminary study. 122
Robotic telepathology for intraoperative remote diagnosis using a still-imaging-based system. 122
Large oncosomes mediate intercellular transfer of functional microRNA. 121
Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays. 120
TMABoost: an integrated system for comprehensive management of tissue microarray data. 120
Tumor clone dynamics in lethal prostate cancer 120
The genomic complexity of primary human prostate cancer. 120
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer 120
Recurrent gene fusions in prostate cancer 119
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. 118
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. 117
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. 117
Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours. 117
Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression 117
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care 117
Charting differentially methylated regions in cancer with Rocker-meth 117
Digital storage of glass slides for quality assurance in histopathology and cytopathology. 116
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression. 116
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer 116
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. 115
Design and initial implementation of a regional tele-oncology project. 114
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. 114
Genetic predisposition to prostate cancer: Update and future perspectives 114
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. 114
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. 113
Integrative clinical genomics of advanced prostate cancer 112
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations 112
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk 112
SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines. 112
Molecular genetics of prostate cancer: Emerging appreciation of genetic complexity 111
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model. 109
V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application. 108
ERG rearrangement metastasis patterns in locally advanced prostate cancer. 108
Totale 14.489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 696
selected - selezionate 0
volume - volumi 392
Totale 89.815
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.439 0 0 0 0 0 182 151 162 161 230 282 271
2021/20222.157 249 327 14 92 36 81 83 390 137 212 181 355
2022/20232.024 267 235 13 328 210 316 30 145 252 34 122 72
2023/2024822 49 77 67 28 76 177 45 92 10 80 32 89
2024/20253.701 18 36 235 669 246 461 205 220 390 579 295 347
2025/20264.198 640 264 982 1.100 896 316 0 0 0 0 0 0
Totale 19.980